Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Stringent Transplant Model

Abstract

These data provide the rationale for development of novel, CNI-free clinical protocols in human transplant recipients.